Skip to main content

Grand Challenges

Bill & Melinda Gates Foundation

Main menu

  • About
  • Challenges
  • Awarded Grants
  • News
  • Grant Opportunities
  • Search

You are here

  1. Home
  2. Awarded Grants

Print link

Print

Maternal Blood Biomarkers to Assess Fetal Neurodevelopment

Grand Challenges ExplorationsBrain Function/Gestational Age23 Oct 2014

Laura Goetzl of Temple University in the U.S. will analyze whether the presence of specific microRNAs in maternal blood during early pregnancy can act as biomarkers of fetal neurodevelopment. Although the causes of neurological disorders such as autism are mostly unknown, they likely involve early defects in neurodevelopment. However, there is no simple, low-cost method for monitoring fetal neurodevelopment. They will identify candidate microRNA molecules at different stages of pregnancy in the blood of women who have elected termination that correlate with neurodevelopmental parameters in fetal brain tissue such as cell types and levels of cell death. They will also analyze blood from women exposed to alcohol during pregnancy to identify the microRNAs associated with abnormal neurodevelopment.

More information about Explore New Ways to Measure Fetal and Infant Brain Development (Round 13)

Share This Awarded Grant

  • Twitter logo Twitter
  • Facebook logo Facebook
  • LinkedIn logo LinkedIn
  • Google+ logo Google+
  • Mailto logo Mailto

Principal Investigator

Laura Goetzl

Organization

Temple University

Location

Philadelphia, Pennsylvania
United States

Contact us

Contact us

  • General Inquiries
  • Media Inquiries

Footer - Receive Updates

Receive updates

  • Sign up for email updates

Footer

  • Privacy Policy and Terms of Use
© 2003-2019. Grand Challenges. All Rights Reserved.

PLEASE REVIEW OUR UPDATED PRIVACY & COOKIES NOTICE

This site uses cookies and similar technologies to store information on your computer or device. By continuing to use this site, you agree to the placement of these cookies and similar technologies. Read our updated Privacy & Cookies Notice to learn more.